Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
4
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen ~26 kDa
species reactivity
human
concentration
~1.0 mg/mL
technique(s)
western blot: 1-2 μg/mL using lysates of HEK-293T cells over-expressing human OSTF1.
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... OSTF1(26578)
General description
Osteoclast-stimulating factor (OSF or OSTF1) gene is mapped to human chromosome 9q21.13 and is expressed in osteoclasts (OCL) as well as motor neurons. OSF is a small intracellular protein and comprises an N-terminal proline-rich region SRC Homology 3 (SH3) domain, three ankyrin repeats and a C-terminal aspartate-rich region. Structurally, OCF protein takes up a β‐barrel fold.
Immunogen
peptide corresponding to the C- terminal region of human OSTF1 conjugated to KLH. The corresponding sequence differs by two or three amino acids in mouse or rat, respectively.
Application
Anti-OSTF1 (C-terminal) antibody produced in rabbit may be used in immunoblotting.
Biochem/physiol Actions
Anti-OSTF1 (C-terminal) recognizes human OSTF1.
Osteoclast-stimulating factor (OSF or OSTF1) SRC Homology 3 (SH3) domain undergoes conformational changes to bind to proline-rich ligand. The C-terminal ankyrin repeats preferably binds to negative-charged binding partners. OSF-SH3 domain interaction stimulates OCL formation and its inhibition may reduce bone resorption by OCL. A compromised bone resorption functionality in OCL further triggers bone loss and may lead to various bone disorders, including hyperparathyroidism, Paget′s disease, osteoporosis, estrogen deficiency, periodontal disease as well as inflammatory bone loss and bone malignancy. OSF favors OCL formation by interacting with sarcoma proto oncogene (c-Src) and its associated proteins based signaling pathway. OSF is implicated in the pathophysiology of spinal muscular atrophy by its possible interaction with survival motor neuron (SMN) proteins through SH3 domain.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Preparation Note
For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Structure of the SH3 domain of human osteoclast-stimulating factor at atomic resolution
Chen L, et al.
Acta Crystallographica Section F, Structural Biology and Crystallization Communications, 844-844 (2006)
Matthieu Vermeren et al.
Mammalian genome : official journal of the International Mammalian Genome Society, 28(11-12), 498-514 (2017-09-25)
Osteoclast stimulation factor 1 (OSTF1) is an SH3-domain containing protein that was initially identified as a factor involved in the indirect activation of osteoclasts. It has been linked to spinal muscular atrophy in humans through its interaction with SMN1, and
Crystal structure of human osteoclast stimulating factor.
Shuilong Tong et al.
Proteins, 75(1), 245-251 (2009-01-13)
N Kurihara et al.
The Journal of biological chemistry, 276(44), 41035-41039 (2001-09-12)
We have recently identified and cloned an intracellular peptide termed osteoclast-stimulating factor (OSF) that increases osteoclast (OCL) formation and bone resorption through a cellular signal transduction cascade, possibly through its interaction with c-Src or related family members. To further identify
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service